iSTAR Medical Raises EUR 4 million in Series A Financing

Proceeds to Support Advancement of STARfloTM Glaucoma Implant

Isnes, Belgium (November 21, 2013) – iSTAR Medical SA, a privately held ophthalmic device company and first spinout of Healionics Corporation, today announced it has raised EUR 4.0 million from institutional investors in a Series A financing. The financing was coled by Capricorn Health-Tech Fund NV (CHF) and Société Régionale d’Investissement de Wallonie (SRIW), and included participation from Financière Spin-off Luxembourgeoise (INVESTSUD Group) and Namur Invest – Preface.

Read more